Oculus Innovative Sciences, Inc.(NASDAQ : OCLS)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Loading OCLS News...
Health Technology » Pharmaceuticals Other
|SHPG||Shire PLC Sponsored ADR||-7.91%||166.03||9.9%||$682.82m|
|VRX||Valeant Pharmaceuticals International, Inc.||-8.85%||20.28||7.1%||$590.12m|
|PRGO||Perrigo Co. Plc||-4.44%||90.97||4.0%||$246.55m|
|ENDP||Endo International Plc||-6.25%||14.85||4.1%||$131.38m|
|JAZZ||Jazz Pharmaceuticals Plc||-4.90%||137.90||2.7%||$122.88m|
|ICPT||Intercept Pharmaceuticals, Inc.||-7.35%||142.92||13.8%||$89.19m|
|HZNP||Horizon Pharma plc||-6.82%||16.25||9.7%||$64.47m|
|UTHR||United Therapeutics Corporation||-3.01%||102.11||19.5%||$61.35m|
|GWPH||GW Pharmaceuticals PLC Sponsored ADR||-6.54%||83.31||12.2%||$37.71m|
Oculus Innovative Sciences, Inc. is a global healthcare company that designs, manufactures and markets prescription and non-prescription products. It offers advanced wound management, nursing home and healthcare, dermatology, wound and skin care for consumers, animal healthcare, and natural healthcare products. The company was founded by Hojabr Alimi and Linda Alimi in April 1999 and is headquartered in Petaluma, CA.